Revising labeling to limit pediatric use
Silver Spring, Maryland—(ENEWSPF)—January 11, 2018
By: Tara Rabin
The U.S. Food and Drug Administration announced today that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population. After safety labeling changes are made, these products…
